Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetRevenue - Other
Ratios

Cartesian Therapeutics (RNAC) Preferred Shares Issued (2023 - 2024)

Cartesian Therapeutics (RNAC) has disclosed Preferred Shares Issued for 2 consecutive years, with $40.0 million as the latest value for Q1 2024.

  • Quarterly Preferred Shares Issued changed N/A to $40.0 million in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $40.0 million through Dec 2024, up 97.53% year-over-year, with the annual reading at $40.0 million for FY2024, 97.53% up from the prior year.
  • Preferred Shares Issued for Q1 2024 was $40.0 million at Cartesian Therapeutics, up from $20.2 million in the prior quarter.
  • The five-year high for Preferred Shares Issued was $40.0 million in Q1 2024, with the low at $20.2 million in Q4 2023.